Ahmadvand Hassan, Shahsavari Gholamreza, Tavafi Majid, Bagheri Shahrokh, Moradkhani Mohamad Reza, Kkorramabadi Reza Mohammadrezaei, Khosravi Peyman, Jafari Maryam, Zahabi Khadije, Eftekhar Reza, Soleimaninejad Maryam, Moghadam Sanaz
Razi Herbal Researches Center, Lorestan University of Medical Sciences, Khorramabad, Iran.
Department of Biochemistry, Faculty of Medicine, Lorestan University of Medical Sciences, Khorramabad, Iran.
J Nephropathol. 2017 Jul;6(3):204-209. doi: 10.15171/jnp.2017.34. Epub 2017 Feb 20.
Oleuropein is a potent antioxidant and free-radical scavenger with antiinflammatory properties.
In the present study, we evaluated the protective effects of oleuropein on myeloperoxidase (MPO) activity, nitrite, urea, creatinine and glomerulosclerosis in alloxan-induced type 1 diabetic rats.
Thirty Sprague-Dawley male rats were randomly divided into 3 groups: group 1 as control; group 2 as untreated diabetic; and group 3 as treated with oleuropein 15 mg/kg i.p daily. Diabetes was induced in the second and third groups by subcutaneous alloxan injection. After 48 days, the animals were anaesthetized and then the livers and kidneys were removed immediately and used fresh or kept frozen until MPO activity analysis. Blood samples were also collected before sacrificing to measure nitrite, urea, and creatinine. Kidney paraffin sections were prepared to estimate glomerular volume, leukocyte infiltration, and glomerulosclerosis.
Oleuropein significantly decreased leukocyte infiltration and glomerulosclerosis in the treated group compared with the diabetic untreated group. Oleuropein significantly decreased the levels of urea, nitrite, and creatinine in the treated group compared with the diabetic untreated group. Moreover, oleuropein significantly decreased MPO activity in the treated group compared with the diabetic untreated group.
Oleuropein has antioxidative and antiatherogenic activities and exerts beneficial effects on inflammation and kidney function test and decreases diabetic complication in diabetic rats.
橄榄苦苷是一种具有抗炎特性的强效抗氧化剂和自由基清除剂。
在本研究中,我们评估了橄榄苦苷对四氧嘧啶诱导的1型糖尿病大鼠髓过氧化物酶(MPO)活性、亚硝酸盐、尿素、肌酐和肾小球硬化的保护作用。
30只雄性Sprague-Dawley大鼠随机分为3组:第1组为对照组;第2组为未治疗的糖尿病组;第3组为每天腹腔注射15mg/kg橄榄苦苷治疗组。通过皮下注射四氧嘧啶使第2组和第3组诱发糖尿病。48天后,将动物麻醉,然后立即取出肝脏和肾脏,新鲜使用或冷冻保存直至进行MPO活性分析。在处死前还采集血样以测量亚硝酸盐、尿素和肌酐。制备肾脏石蜡切片以评估肾小球体积、白细胞浸润和肾小球硬化。
与未治疗的糖尿病组相比,治疗组中橄榄苦苷显著降低了白细胞浸润和肾小球硬化。与未治疗的糖尿病组相比,治疗组中橄榄苦苷显著降低了尿素、亚硝酸盐和肌酐水平。此外,与未治疗的糖尿病组相比,治疗组中橄榄苦苷显著降低了MPO活性。
橄榄苦苷具有抗氧化和抗动脉粥样硬化活性,对炎症和肾功能检测具有有益作用,并可降低糖尿病大鼠的糖尿病并发症。